Company Profile

Immunathon Inc (AKA: Emmune Inc)
Profile last edited on: 12/15/2023      CAGE: 7A4Z5      UEI: N65ZDYUGWAH8

Business Identifier: Re-targeting immune system to fight cancer.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1951 Nw 7th Avenue Suite 300
Miami, FL 33136
   (305) 392-0749
Location: Single
Congr. District: 24
County: Miami-Dade

Public Profile

Efforts to redirect the immune system to kill cancer cells have generated extraordinary hope and interest, but face the fundamental problem of how to avoid also killing healthy cells. To overcome this obstacle, the principals of Immunathon have invented a new targeting mechanism, activated by abnormal patterns of gene expression that are hallmarks of cancer. Involved inthe Mass Challenge during 2014, and with close ties ot Harvard and Draper Labs, the principals of the firm indicate intent to partner with biotech and pharmaceutical companies, and generate for them cancer immunotherapy drugs with dramatically improved safety and efficacy.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Michael David Alpert -- President

  Jennifer Rainho

Company News

There are no news available.